Home World News FDA Approves New Interchangeable Biosimilar to Pertuzumab World News FDA Approves New Interchangeable Biosimilar to Pertuzumab By Ogkologos - December 3, 2025 449 0 Facebook Twitter Google+ Pinterest WhatsApp Approval is based on comparisons across a broad range of structural and functional product quality attributes Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Husband Turns Wife’s Inspiring Poem for Her Daughters into a Book... February 25, 2020 Breast Cancer Survivor’s Family Designs a Holiday Light Show in Her... December 15, 2020 Nivolumab Achieves High ORR and Durable PFS in Patients with dMMR/MSI-H... May 3, 2024 KRASG12D-Mutated NSCLC is Subtype with Distinct Co-mutations, a Colder Immune Microenvironment,... August 3, 2022 Load more HOT NEWS A tribute to Professor Gordon McVie England: Smoking responsible for twice as many cancers in most deprived... Holidays, Traditions and Grief Combination Therapy for Metastatic Prostate Cancer Helps Some Men Live Longer